8th Annual Tumour Models, San Francisco, CA, Jan 30-Feb 01, 2024

Conference

genOway presentation

Event
-
January 23, 2024

Jan 30-Feb 01, 2024

Implementing State-of-the-Art, Reproducible Preclinical Oncology Models to Accelerate Your Candidate’s Clinical Translatability

8th Tumour Models San Francisco

genOway’s presentation:

How to enhance translatability of immunotherapies in preclinical models

  • Outlining BRGSF-HIS mice: Immunodeficient mice displaying functional human lymphoid and myeloid compartments, without GvHD and side effects
  • Examining human cells functionality and assessing immune modulation induced by biologics in BRGSF-HIS model
  • Showcase of assessment of immune targeting agents in immune checkpoint humanized models

Other news & events

AACR Annual Meeting 2025, Chicago, IL, April 25-30
Conference
genOway presentation
Event
-
Apr 2025
Read on
7th Treg-Directed Therapies Summit 2025, Boston, MA, March 25-27, 2025
Conference
Event
-
Mar 2025
Read on
NextGen Biomed 2025, London, UK, March 12-14, 2025
Conference
Event
-
Feb 2025
Read on
genOway signs a three-year contract with a global philanthropic organization supporting the development of infectious diseases therapies
Partnership
News
-
Feb 2025
Read on
9th Tumor Models San Francisco Summit 2025, January 29-30, 2025
Conference
genOway presentation
Event
-
Jan 2025
Read on